Injective wavers with persistent weakness below key levels, testing support while volatility remains elevated

Traders Union
All News
Crypto
Injective slips 7.55% this week

Highlights

INJ is trading at $3.25, just above its MA-20 ($3.21) but significantly below the MA-50 ($4.08) and MA-200 ($8.03), indicating continued medium- and long-term selling pressure.
Daily chart momentum indicators such as MACD and ADX signal firm bearish momentum, while RSI at 41.26 and other oscillators remain neutral, suggesting weak but not extreme market sentiment.
INJ is expected to consolidate between $2.93 and $3.57 over the next five days, with key resistance at $3.38 and further downside risk if support at $2.93 breaks.

Enhanced token deflation spurs sentiment after Injective 2.0 upgrade

Injective is a Layer 1 blockchain purpose-built for decentralized finance applications, featuring a fully decentralized order book and zero gas fees for traders. The network leverages the Cosmos SDK and Tendermint consensus, enabling cross-chain interoperability through IBC transfers. Trading fees collected on its Helix exchange contribute to validator rewards and regular INJ token burns, with the recent Injective 2.0 upgrade significantly enhancing token deflationary mechanics.

Choppy trading potential as bearish momentum persists over the week

On the weekly timeframe, INJ has stabilized just above the MA-20 with resistance overhead at the Ichimoku Kijun level of $3.38 and downside support near the MA-20. The weekly MACD and RSI both signal ongoing bearish momentum, with the RSI reading at 41.26 showing persistent weakness but not approaching oversold conditions. Weekly oscillators, including Stochastic RSI and Commodity Channel Index, remain neutral, while Bull/Bear Power provides a slight bullish tilt, indicating a potential for choppy trading action.

Consolidation favored as upside risks remain limited in the coming week

Over the next five to seven trading days, INJ is expected to consolidate within a range of $2.93 — $3.57, reflecting recent weekly volatility and continued downward pressure from long-term moving averages. There is a low probability of a sustained upside move, with a more likely scenario being sideways or slightly bearish action unless resistance at $3.38 is decisively breached. A break below $2.93 could trigger further declines, while holding above the MA-20 may support short-term consolidation.

Jainam Mehta, market strategist, notes that Injective held modest gains this week, stabilizing above its MA-20 while still facing clear resistance from longer-term moving averages. He sees technical momentum continuing to favor consolidation, with oscillators mixed and a low probability of an upside breakout unless the $3.38 level is cleared. Mehta highlights that persistent bearish signals should keep traders defensive, but slight bullish undercurrents could make for choppy action within the established range. "I expect INJ to remain range-bound between $2.93 and $3.57 this week, and only a decisive move above $3.38 would shift my bias away from a cautious, consolidation-focused outlook."

Previously it was reported that Injective remains under broad downward pressure, trading below all major moving averages and approaching session lows following a sharp daily decline, with momentum indicators such as MACD and ADX confirming a strong, active downtrend. Resistance is identified at the Ichimoku Kijun level, while mixed signals from oscillators offer limited support amid weak overall sentiment, suggesting a continued bearish to sideways near-term outlook.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.